Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Am J Hematol. 1997 Mar;54(3):209-13. doi: 10.1002/(sici)1096-8652(199703)54:3<209::aid-ajh6>3.0.co;2-#.
Annexin V has a calcium-dependent binding affinity for anionic phospholipids and activated platelets, and prevents prothrombinase activity. We investigated the clinical significance of IgG anti-annexin V antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG anti-annexin V antibodies by ELISA. IgG anti-annexin V antibodies were detected in 27 of 140 patients (19%). Significantly higher incidences of arterial or venous thrombosis, intrauterine fetal loss, and prolonged activated partial thromboplastin time were found in patients with anti-annexin V antibodies than in those without anti-annexin V antibodies. Three patients with thrombosis were found not to have anticardiolipin antibodies, but to show sustained serological reactions for anti-annexin V antibodies, irrespective of prednisolone administration. These results indicated the clinical characteristics of SLE patients with anti-annexin V antibodies, and that these antibodies may be associated with the pathogenesis of thrombotic events.
膜联蛋白V对阴离子磷脂和活化血小板具有钙依赖性结合亲和力,并可抑制凝血酶原酶活性。我们研究了SLE患者中IgG抗膜联蛋白V抗体的临床意义。研究对象包括140例SLE患者。采用ELISA法检测血清中IgG抗膜联蛋白V抗体。140例患者中有27例(19%)检测到IgG抗膜联蛋白V抗体。与无抗膜联蛋白V抗体的患者相比,有抗膜联蛋白V抗体的患者发生动脉或静脉血栓形成、宫内胎儿丢失以及活化部分凝血活酶时间延长的发生率显著更高。发现3例血栓形成患者无抗心磷脂抗体,但无论是否使用泼尼松龙,均显示出抗膜联蛋白V抗体的持续血清学反应。这些结果表明了具有抗膜联蛋白V抗体的SLE患者的临床特征,并且这些抗体可能与血栓形成事件的发病机制有关。